Skip to search formSkip to main contentSkip to account menu

Hematologic Neoplasms

Known as: Hematologic Neoplasms [Disease/Finding], Neoplasm, Hematological, Malignancy, Hematologic 
Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA… 
National Institutes of Health

Related topics

Related topics

11 relations

Narrower (1)

Hematopoietic Neoplasms
In BloodLiquid TumorLymphomaMicrobiological

Broader (1)

Malignant tumor of lymphoid hemopoietic and related tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.
  • E. Jaffe
  • Hematology. American Society of Hematology…
  • 2009
  • Corpus ID: 5910575
The 4(th) edition of the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues published in 2008 builds upon the… 
Highly Cited
2007
Highly Cited
2007
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
BACKGROUND Treatment of invasive mold infection in immunocompromised patients remains challenging. Voriconazole has been shown to… 
Highly Cited
2007
Highly Cited
2007
Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial
Summary.  Background: Soluble thrombomodulin is a promising therapeutic natural anticoagulant that is comparable to antithrombin… 
Review
2004
Review
2004
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
The dipeptide boronic acid analogue VELCADE™ (Bortezomib; formerly known as PS-341, LDP-341 and MLM341) is a potent and selective… 
Highly Cited
1998
Highly Cited
1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow…
We report the results of a phase III open-label, randomized, multicenter trial comparing tacrolimus/methotrexate to cyclosporine… 
Review
1997
Review
1997
Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.
Despite increasing reports of life-threatening Fusarium infections, little is known about its pathogenesis and management. To… 
Highly Cited
1992
Highly Cited
1992
Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.
OBJECTIVE To determine whether glutamine-supplemented parenteral nutrition improves nitrogen retention and reduces hospital… 
Review
1992
Review
1992
Retinoids in cancer therapy.
PURPOSE Recent reports of the dramatic antitumor effect of all-trans retinoic acid (RA) in patients with acute promyelocytic… 
Review
1990
Review
1990
The soluble interleukin-2 receptor: biology, function, and clinical application.
PURPOSE To review the biologic origin, functional characteristics, and current and potential clinical applications of a novel… 
Highly Cited
1981
Highly Cited
1981
Clinical Gynecologic Oncology
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)